You are currently on the new version of our website. Access the old version .

174 Results Found

  • Review
  • Open Access
122 Citations
18,874 Views
28 Pages

13 February 2022

Estrogen and progesterone and their signaling mechanisms are tightly regulated to maintain a normal menstrual cycle and to support a successful pregnancy. The imbalance of estrogen and progesterone disrupts their complex regulatory mechanisms, leadin...

  • Review
  • Open Access
69 Citations
13,524 Views
14 Pages

Endometriosis is an estrogen-dependent disease characterized by the growth of endometrial-like tissue outside the uterus. Progestins are currently the most commonly used treatment for endometriosis because of their excellent therapeutic effects and l...

  • Review
  • Open Access
23 Citations
6,489 Views
16 Pages

MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance

  • Jing-Xian Hon,
  • Norhazlina Abdul Wahab,
  • Abdul Kadir Abdul Karim,
  • Norfilza Mohd Mokhtar and
  • Mohd Helmy Mokhtar

9 October 2023

Endometriosis, a non-malignant gynecological disorder influenced by estrogen, involves the growth of endometrial tissue outside the uterus. Its development includes processes such as inflammation, progesterone resistance, angiogenesis, and cell proli...

  • Article
  • Open Access
4 Citations
3,364 Views
16 Pages

Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line

  • Kosuke Kanno,
  • Kentaro Nakayama,
  • Sultana Razia,
  • Sohel Hasibul Islam,
  • Zahan Umme Farzana,
  • Shahataj Begum Sonia,
  • Hitomi Yamashita,
  • Masako Ishikawa,
  • Tomoka Ishibashi and
  • Kayo Imamura
  • + 2 authors

Although endometriosis is a benign disease, it is associated with cancer-related gene mutations, such as KRAS or PIK3CA. Endometriosis is associated with elevated levels of inflammatory factors that cause severe pain. In a previous study, we demonstr...

  • Review
  • Open Access
126 Citations
19,261 Views
21 Pages

5 March 2021

Background: The first objective of this review was to present, based on recent literature, the most frequently applied medical options (oral contraceptive pills (OCPs) and progestogens) for the management of symptomatic endometriosis, and evaluate th...

  • Article
  • Open Access
2,226 Views
22 Pages

Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience

  • Matilde Degano,
  • Giorgia Vesca,
  • Michela Bulfoni,
  • Silvia Zermano,
  • Stefano Restaino,
  • Martina Arcieri,
  • Errico Zupi,
  • Renato Seracchioli,
  • Lorenza Driul and
  • Daniela Cesselli
  • + 3 authors

27 March 2025

This feasibility study explores the potential of salivary microRNAs (miRNAs) as non-invasive biomarkers for diagnosing endometriosis and assessing treatment response. Almost one-third of patients with endometriosis do not respond to the standard prog...

  • Review
  • Open Access
14 Citations
4,864 Views
16 Pages

24 March 2022

Endometriosis is a significant disease characterized by infertility and pelvic pain in which endometrial stromal and glandular tissue grow in ectopic locations. Altered responsiveness to progesterone is a contributing factor to endometriosis pathophy...

  • Review
  • Open Access
360 Citations
41,179 Views
28 Pages

Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?

  • Ryan M. Marquardt,
  • Tae Hoon Kim,
  • Jung-Ho Shin and
  • Jae-Wook Jeong

In the healthy endometrium, progesterone and estrogen signaling coordinate in a tightly regulated, dynamic interplay to drive a normal menstrual cycle and promote an embryo-receptive state to allow implantation during the window of receptivity. It is...

  • Article
  • Open Access
3 Citations
2,313 Views
20 Pages

Exploring the Role of MicroRNAs in Progesterone and Estrogen Receptor Expression in Endometriosis

  • Jing-Xian Hon,
  • Norhazlina Abdul Wahab,
  • Abdul Kadir Abdul Karim,
  • Norfilza Mohd Mokhtar and
  • Mohd Helmy Mokhtar

28 September 2024

Background/Objectives: Patients with endometriosis still respond poorly to progestins due to progesterone resistance associated with microRNAs (miRNAs). The aim of this study was to investigate the expression of selected miRNAs, estrogen receptor (ER...

  • Review
  • Open Access
4 Citations
8,730 Views
14 Pages

A History of Neonatal Uterine Bleeding and Its Significance

  • Giuseppe Benagiano,
  • Marwan Habiba,
  • Donatella Lippi and
  • Ivo A. Brosens

10 December 2021

Bleeding in newborns and young girls fascinated writers for more than a millennium. Initially, there was confusion between neonatal bleeding, early menstruation due to precocious puberty, and hemorrhage due to disease. During the 19th century descrip...

  • Review
  • Open Access
20 Citations
9,097 Views
17 Pages

Polycystic ovary syndrome (PCOS) is a major anovulatory infertility affecting a great proportion of women of childbearing age and is associated with obesity, insulin resistance and chronic inflammation. Poor endometrial receptivity and recurrent impl...

  • Article
  • Open Access
8 Citations
2,780 Views
12 Pages

MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer

  • Olivia Jeong,
  • Russell R. Broaddus,
  • Bruce A. Lessey,
  • John I. Risinger,
  • Mark I. Hunter and
  • Tae Hoon Kim

23 November 2022

Women with complex atypical hyperplasia (CAH) or early-stage endometrioid endometrial cancer (EEC) are candidates for fertility preservation. The most common approach is progesterone (P4) therapy and deferral of hysterectomy until after completion of...

  • Review
  • Open Access
28 Citations
4,120 Views
21 Pages

Progestins as Anticancer Drugs and Chemosensitizers, New Targets and Applications

  • Tatiana A. Fedotcheva,
  • Nadezhda I. Fedotcheva and
  • Nikolai L. Shimanovsky

Progesterone and its synthetic analogues, progestins, participate in the regulation of cell differentiation, proliferation and cell cycle progression. Progestins are usually applied for contraception, maintenance of pregnancy, and hormone replacement...

  • Review
  • Open Access
53 Citations
12,008 Views
25 Pages

FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer

  • Darcie D. Seachrist,
  • Lindsey J. Anstine and
  • Ruth A. Keri

17 October 2021

The pioneering function of FOXA1 establishes estrogen-responsive transcriptomes in luminal breast cancer. Dysregulated FOXA1 chromatin occupancy through focal amplification, mutation, or cofactor recruitment modulates estrogen receptor (ER) transcrip...

  • Article
  • Open Access
11 Citations
3,319 Views
13 Pages

Estetrol Increases Progesterone Genetic Response without Triggering Common Estrogenic Effects in Endometriotic Cell Lines and Primary Cultures

  • Daniel Patiño-García,
  • Jaime Palomino,
  • Cristián Pomés,
  • Claudia Celle,
  • Verónica Torres-Estay and
  • Renán Orellana

Estetrol (E4), a natural estrogen produced by the human fetal liver, is actively studied for menopause and breast cancer treatment. It has low side effects and preferential estrogen receptor alpha (ERα) affinity. There are no data about its eff...

  • Review
  • Open Access
44 Citations
11,061 Views
12 Pages

Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists

  • Jacques Donnez,
  • Christina Anna Stratopoulou and
  • Marie-Madeleine Dolmans

Uterine adenomyosis is a common chronic disorder frequently encountered in reproductive-age women, causing heavy menstrual bleeding, intense pelvic pain, and infertility. Despite its high prevalence, its etiopathogenesis is not yet fully understood,...

  • Review
  • Open Access
39 Citations
12,238 Views
15 Pages

20 October 2021

To evaluate the effectiveness of a new class of medical drugs, namely oral gonadotropin-releasing hormone (GnRH) antagonists, in the management of premenopausal women with endometriosis-associated pelvic pain. We reviewed the most relevant papers (n...

  • Article
  • Open Access
5 Citations
4,622 Views
16 Pages

SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner

  • Hany A. Abdel-Hafiz,
  • Michelle L. Dudevoir,
  • Daniel Perez,
  • Mohamed Abdel-Hafiz and
  • Kathryn B. Horwitz

Luminal breast cancers express estrogen (ER) and progesterone (PR) receptors, and respond to endocrine therapies. However, some ER+PR+ tumors display intrinsic or acquired resistance, possibly related to PR. Two PR isoforms, PR-A and PR-B, regulate d...

  • Article
  • Open Access
6 Citations
2,765 Views
20 Pages

20 December 2023

C11-oxy C19 and C11-oxy C21 steroids have been identified as novel steroids but their function remains unclear. This study aimed to investigate the pre-receptor regulation of C11-oxy steroids by 11β-hydroxysteroid dehydrogenase (11βHSD) int...

  • Review
  • Open Access
24 Citations
6,381 Views
14 Pages

Emerging Drug Targets for Endometriosis

  • Marie-Madeleine Dolmans and
  • Jacques Donnez

8 November 2022

Endometriosis is a chronic inflammatory disease causing distressing symptoms and requiring a life-long management strategy. The objective of this review is to evaluate endometriosis-related pathways and identify novel therapies to treat it. We focuse...

  • Article
  • Open Access
3 Citations
3,498 Views
12 Pages

Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis

  • Christina Anna Stratopoulou,
  • Ines El Grari,
  • Alessandra Camboni,
  • Jacques Donnez and
  • Marie-Madeleine Dolmans

24 August 2024

Background/Objectives: While it is known that adenomyosis is associated with poor reproductive outcomes, the underlying mechanisms are unclear, and to date, there is no standard treatment protocol for these patients. Endometrium from adenomyosis pati...

  • Article
  • Open Access
9 Citations
7,627 Views
12 Pages

Adiposity is Associated with Decreased Serum 17-Hydroxyprogesterone Levels in Non-Diabetic Obese Men Aged 18–49: A Cross-Sectional Study

  • José Ignacio Martínez-Montoro,
  • María Molina-Vega,
  • Maite Asenjo-Plaza,
  • María Concepción García-Ruiz,
  • Enrique Varea-Marineto,
  • Isaac Plaza-Andrade,
  • Juan J. Álvarez-Millán,
  • Pablo Cabezas-Sánchez,
  • Francisco J. Tinahones and
  • José Carlos Fernández-García

28 November 2020

Obesity is associated with decreased circulating testosterone levels, the main male sex hormone. However, there are a number of different male sex hormones whose dynamics remain poorly understood regarding this pathology. In this regard, 17 hydroxypr...

  • Article
  • Open Access
10 Citations
3,968 Views
16 Pages

RETRACTED: Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro

  • Ana Paucarmayta,
  • Hannah Taitz,
  • Latoya McGlorthan,
  • Yovanni Casablanca,
  • G. Larry Maxwell,
  • Kathleen M. Darcy and
  • Viqar Syed

Initially, patients that respond to cisplatin (DDP) treatment later relapse and develop chemoresistance. Agents that enhance DDP effectiveness will have a significant impact on cancer treatment. We have shown pronounced inhibitory effects of the prog...

  • Article
  • Open Access
1 Citations
2,748 Views
14 Pages

Effect of 17β-Estradiol, Progesterone, and Tamoxifen on Neurons Infected with Toxoplasma gondii In Vitro

  • María de la Luz Galván Ramírez,
  • Judith Marcela Dueñas-Jiménez,
  • Adrián Fernando Gutiérrez-Maldonado and
  • Laura Rocío Rodríguez Pérez

Toxoplasma gondii (T. gondii) is the causal agent of toxoplasmosis, which produces damage in the central nervous system (CNS). Toxoplasma–CNS interaction is critical for the development of disease symptoms. T. gondii can form cysts in the CNS; howeve...

  • Article
  • Open Access
5 Citations
3,081 Views
12 Pages

Progesterone Has No Impact on the Beneficial Effects of Estradiol Treatment in High-Fat-Fed Ovariectomized Mice

  • Carlos H. Z. Talarico,
  • Ester S. Alves,
  • Jessica D. M. Dos Santos,
  • Felipe G. S. Sucupira,
  • Layanne C. C. Araujo and
  • João Paulo Camporez

In recent decades, clinical and experimental studies have revealed that estradiol contributes enormously to glycemic homeostasis. However, the same consensus does not exist in women during menopause who undergo replacement with progesterone or conjug...

  • Article
  • Open Access
14 Citations
3,755 Views
21 Pages

Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models

  • Subrata Deb,
  • Steven Pham,
  • Dong-Sheng Ming,
  • Mei Yieng Chin,
  • Hans Adomat,
  • Antonio Hurtado-Coll,
  • Martin E. Gleave and
  • Emma S. Tomlinson Guns

20 September 2018

Castration-resistant prostate tumors acquire the independent capacity to generate androgens by upregulating steroidogenic enzymes or using steroid precursors produced by the adrenal glands for continued growth and sustainability. The formation of ste...

  • Article
  • Open Access
10 Citations
2,893 Views
12 Pages

22 September 2023

(1) Background: Infertility is a prevalent issue that affects 10–18% of couples worldwide, and up to 30% in Eastern Europe. Infertility of unknown etiology is one of the most challenging forms of infertility. Vitamin D has recently been extensi...

  • Article
  • Open Access
7 Citations
3,201 Views
15 Pages

Highly Expressed Progesterone Receptor B Isoform Increases Platinum Sensitivity and Survival of Ovarian High-Grade Serous Carcinoma

  • Hao Lin,
  • Kuo-Chung Lan,
  • Yu-Che Ou,
  • Chen-Hsuan Wu,
  • Hong-Yo Kang,
  • I-Chieh Chuang and
  • Hung-Chun Fu

8 November 2021

Background: Expression of the progesterone receptor (PR) has been reported to influence survival outcomes in patients with ovarian high-grade serous carcinoma (HGSC). In the present study, we attempted to investigate the association among PR and its...

  • Review
  • Open Access
1,612 Views
20 Pages

Steroid hormones play critical roles in the development and progression of NSCLC through both genomic and non-genomic pathways. This review summarizes the expression profiles and molecular functions of estrogen, progesterone, androgen, and glucocorti...

  • Article
  • Open Access
5 Citations
2,483 Views
11 Pages

Lung Function Variation during the Estrus Cycle of Mares Affected by Severe Asthma

  • Sophie Mainguy-Seers,
  • Mouhamadou Diaw and
  • Jean-Pierre Lavoie

17 February 2022

While the prevalence of asthma is higher in boys than in girls during childhood, this tendency reverses at puberty, suggesting an effect of sex hormones on the disease pathophysiology. Fluctuations of asthma severity concurring with the estrus cycle...

  • Article
  • Open Access
19 Citations
6,224 Views
14 Pages

Bacterial resistance is caused by several biochemical factors, the formation of biofilm being one of the main causes. This process is triggered by Quorum Sensing (QS), through the production of endogenous molecules, although other substances such as...

  • Article
  • Open Access
75 Citations
8,557 Views
13 Pages

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models

  • Janine van der Giessen,
  • C. Janneke van der Woude,
  • Maikel P. Peppelenbosch and
  • Gwenny M. Fuhler

19 March 2019

Background: Pregnancy is often described as an immune-tolerant state, and a disease modulatory role for pregnancy on inflammatory bowel disease (IBD) has been suggested. The direct effect of estrogen and progesterone on the intestinal epithelial barr...

  • Article
  • Open Access
9 Citations
3,031 Views
13 Pages

Toxoplasma gondii (T. gondii), as an opportunistic pathogen, has special pathogenic effects on pregnant animals and humans. Progesterone (P4) is a critical hormone that supports pregnancy, and its levels fluctuate naturally during early pregnancy. Ho...

  • Review
  • Open Access
6 Citations
8,876 Views
30 Pages

Progesterone-Related Diabetes Mellitus in the Bitch: Current Knowledge, the Role of Pyometra, and Relevance in Practice

  • Álan Gomes Pöppl,
  • José Lucas Xavier Lopes,
  • Taís Bock Nogueira,
  • Denise Iparraguirre da Silva and
  • Bruna dos Santos Machado

14 March 2024

Progesterone-related diabetes mellitus (PRDM) in dogs is known for its particular potential for diabetes remission. This narrative review aims to provide relevant detailed information on (1) the canine estrus cycle and its impact on canine diabetes m...

  • Article
  • Open Access
1 Citations
3,029 Views
23 Pages

ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines

  • Petr Daniel,
  • Kamila Balušíková,
  • Radka Václavíková,
  • Karolína Šeborová,
  • Šárka Ransdorfová,
  • Marie Valeriánová,
  • Longfei Wei,
  • Michael Jelínek,
  • Tereza Tlapáková and
  • Thomas Fleischer
  • + 4 authors

23 January 2023

A limited number of studies are devoted to regulating TRIP6 expression in cancer. Hence, we aimed to unveil the regulation of TRIP6 expression in MCF-7 breast cancer cells (with high TRIP6 expression) and taxane-resistant MCF-7 sublines (manifesting...

  • Article
  • Open Access
21 Citations
4,125 Views
16 Pages

PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers

  • Min Yang,
  • Jean Chong Li,
  • Chang Tao,
  • Sa Wu,
  • Bin Liu,
  • Qiang Shu,
  • Benyi Li and
  • Runzhi Zhu

18 September 2021

Progesterone-induced rapid non-genomic signaling events have been confirmed through several membrane progesterone receptors (mPR). Some mPRs were reported to correlate with cancer progression and patient prognosis. In this study, we conducted a compr...

  • Review
  • Open Access
53 Citations
6,886 Views
23 Pages

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications

  • Emma Zattarin,
  • Rita Leporati,
  • Francesca Ligorio,
  • Riccardo Lobefaro,
  • Andrea Vingiani,
  • Giancarlo Pruneri and
  • Claudio Vernieri

9 December 2020

Hormone receptor-positive breast cancer (HR+ BC) accounts for approximately 75% of new BC diagnoses. Despite the undisputable progresses obtained in the treatment of HR+ BC in recent years, primary or acquired resistance to endocrine therapies still...

  • Article
  • Open Access
14 Citations
2,914 Views
16 Pages

Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue

  • Subrata Deb,
  • Mei Yieng Chin,
  • Steven Pham,
  • Hans Adomat,
  • Antonio Hurtado-Coll,
  • Martin E. Gleave and
  • Emma S. Tomlinson Guns

The peripheral zone (PZ) and transition zone (TZ) represent about 70% of the human prostate gland with each zone having differential ability to develop prostate cancer. Androgens and their receptor are the primary driving cause of prostate cancer gro...

  • Article
  • Open Access
30 Citations
5,440 Views
17 Pages

Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-Like Symptoms

  • Po-Han Lin,
  • Chih-Chao Chang,
  • Kun-Hsuan Wu,
  • Chun-Kuang Shih,
  • Wenchang Chiang,
  • Hsin-Yuan Chen,
  • Yin-Hwa Shih,
  • Kei-Lee Wang,
  • Yong-Han Hong and
  • Tzong-Ming Shieh
  • + 1 author

Women with polycystic ovary syndrome (PCOS) have been reported to have an elevated serum advanced glycation end product (AGE) level. However, the effect of AGEs on the pathophysiological ovarian granulosa cells of PCOS is still unclear. In this study...

  • Article
  • Open Access
1 Citations
2,293 Views
12 Pages

Sepia pharaonis Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome

  • Prathyusha Yamarthi,
  • Rama Satyasri Kotipalli,
  • Samatasai Patnaik,
  • Kv Veena,
  • Muralidharan Kathirvel,
  • Rajkumar Vutukuri and
  • Manjula Bhanoori

The present study aims to evaluate the effect of Sepia pharaonis ink on insulin resistance in PCOS-induced mice. Treatment with sepia ink in dehydroepiandrosterone (DHEA)-induced PCOS mice at various doses of 50 mg/kg, 100 mg/kg, and 200&thins...

  • Review
  • Open Access
5 Citations
3,219 Views
18 Pages

13 May 2024

Low-grade serous ovarian cancer (LGSOC) is a rare ovarian malignancy primarily affecting younger women and is characterized by an indolent growth pattern. It exhibits indolent growth and high estrogen/progesterone receptor expression, suggesting pote...

  • Article
  • Open Access
23 Citations
5,995 Views
11 Pages

Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients

  • Nada Lallous,
  • Oliver Snow,
  • Christophe Sanchez,
  • Ana Karla Parra Nuñez,
  • Bei Sun,
  • Ahmed Hussain,
  • Joseph Lee,
  • Helene Morin,
  • Eric Leblanc and
  • Martin E. Gleave
  • + 1 author

11 June 2021

Resistance to drug treatments is common in prostate cancer (PCa), and the gain-of-function mutations in human androgen receptor (AR) represent one of the most dominant drivers of progression to resistance to AR pathway inhibitors (ARPI). Previously,...

  • Article
  • Open Access
6 Citations
2,984 Views
20 Pages

Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer

  • Yiyang Li,
  • Wei Zhou,
  • Xiangbing Meng,
  • Sarina D. Murray,
  • Long Li,
  • Abby Fronk,
  • Vanessa J. Lazaro-Camp,
  • Kuo-kuang Wen,
  • Meng Wu and
  • Adam Dupuy
  • + 2 authors

6 October 2022

Expression of progesterone receptor (PR) is a favorable prognostic marker for multiple solid tumors. However, PR expression is reduced or lost in malignant tumors. Thus, monitoring and restoring functional PR expression is important in order to sensi...

  • Article
  • Open Access
4 Citations
3,011 Views
12 Pages

No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients—A 10-Year Follow-Up Study in the Polish Population

  • Ewa Totoń,
  • Barbara Jacczak,
  • Wojciech Barczak,
  • Paweł Jagielski,
  • Robert Gryczka,
  • Hanna Hołysz,
  • Sylwia Grodecka-Gazdecka and
  • Błażej Rubiś

21 April 2022

Many intensive studies are devoted to identifying novel cancer diagnostics or therapy strategies that would boost cancer therapy efficacy and recovery rates. Importantly, polymorphisms in the genes coding for ABC family proteins were considered good...

  • Article
  • Open Access
12 Citations
2,467 Views
18 Pages

Resveratrol Protects Rat Ovarian Luteinized Granulosa Cells from H2O2-Induced Dysfunction by Activating Autophagy

  • Minghui Cai,
  • Haijuan Sun,
  • Yujia Huang,
  • Haixu Yao,
  • Chen Zhao,
  • Jiao Wang and
  • Hui Zhu

Resveratrol performs a variety of biological activities, including the potential regulation of autophagy. However, it is unclear whether resveratrol protects against luteal dysfunction and whether autophagy involves the regulation of resveratrol. Thi...

  • Review
  • Open Access
5 Citations
2,498 Views
34 Pages

26 February 2025

Breast cancer poses a significant global health challenge and includes various subtypes, such as endocrine-positive, HER2-positive, and triple-negative. Endocrine-positive breast cancer, characterized by estrogen and progesterone receptors, is common...

  • Review
  • Open Access
18 Citations
6,254 Views
22 Pages

From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells

  • Jéssica Fernanda Barazetti,
  • Tayana Shultz Jucoski,
  • Tamyres Mingorance Carvalho,
  • Rafaela Nasser Veiga,
  • Ana Flávia Kohler,
  • Jumanah Baig,
  • Hend Al Bizri,
  • Daniela Fiori Gradia,
  • Sylvie Mader and
  • Jaqueline Carvalho de Oliveira

22 July 2021

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer mortality among women. Two thirds of patients are classified as hormone receptor positive, based on expression of estrogen receptor alpha (ERα), the main driver of br...

  • Review
  • Open Access
10 Citations
8,430 Views
17 Pages

PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer

  • Henan Zhao,
  • Duojiao Li,
  • Baojing Zhang,
  • Yan Qi,
  • Yunpeng Diao,
  • Yuhong Zhen and
  • Xiaohong Shu

20 December 2017

Triple negative breast cancer (TNBC), is defined as a type of tumor lacking the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). The ER, PR and HER2 are usually the molecular therap...

  • Review
  • Open Access
9 Citations
4,749 Views
14 Pages

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk

  • Srdan Pandurevic,
  • Djuro Macut,
  • Flaminia Fanelli,
  • Uberto Pagotto and
  • Alessandra Gambineri

12 September 2021

Polycystic ovary syndrome (PCOS) is extremely heterogeneous in terms of clinical manifestations. The variability of the syndrome’s phenotype is derived from the genetic and molecular heterogeneity, with a great deal of environmental factors that may...

  • Article
  • Open Access
26 Citations
11,150 Views
13 Pages

Triple-negative breast cancer (TNBC) is among the most notorious types of breast cancer, the treatment of which does not give consistent results due to the absence of the three receptors (estrogen receptor (ER), progesterone receptor (PR), and human...

of 4